GD
Grandfield & Dodd Portfolio holdings
AUM
$1.71B
This Quarter Return
+5.07%
1 Year Return
+14.85%
3 Year Return
+57.47%
5 Year Return
+112%
10 Year Return
+284.72%
AUM
$891M
AUM Growth
+$891M
(+5.3%)
Cap. Flow
+$6.04M
Cap. Flow
% of AUM
0.68%
Top 10 Holdings %
Top 10 Hldgs %
27.35%
Holding
187
New
3
Increased
44
Reduced
84
Closed
4
Top Buys
| 1 |
Weyerhaeuser
WY
|
$7.52M |
| 2 |
US Bancorp
USB
|
$5.35M |
| 3 |
M&T Bank
MTB
|
$4.4M |
| 4 |
Johnson Controls International
JCI
|
$3.74M |
| 5 |
Albemarle
ALB
|
$2.51M |
Top Sells
| 1 |
Applied Materials
AMAT
|
$3.88M |
| 2 |
Emerson Electric
EMR
|
$3.84M |
| 3 |
Vodafone
VOD
|
$3.59M |
| 4 |
Enbridge
ENB
|
$2.63M |
| 5 |
Autodesk
ADSK
|
$2.34M |
Sector Composition
| 1 | Technology | 22.23% |
| 2 | Healthcare | 18.16% |
| 3 | Consumer Staples | 10.53% |
| 4 | Industrials | 10.52% |
| 5 | Financials | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Johnson & Johnson
JNJ
$428B
| $13.9M | 1.56% |
107,182
-1,089
| -1% | -$142K |
|
|
UN
27
DELISTED
Unilever NV New York Registry Shares
UN
| $13.4M | 1.51% |
227,243
-933
| -0.4% | -$55.1K |
|
|
28
M&T Bank
MTB
$30.6B
| $12.8M | 1.44% |
79,583
+27,294
| +52% | +$4.4M |
|
29
Verisk Analytics
VRSK
$36.9B
| $12.7M | 1.43% |
153,103
+1,964
| +1% | +$163K |
|
30
Zimmer Biomet
ZBH
$20.9B
| $12.5M | 1.41% |
106,946
+4,610
| +5% | +$540K |
|
31
eBay
EBAY
$41B
| $12.5M | 1.4% |
324,556
+5,122
| +2% | +$197K |
|
32
Sanofi
SNY
$120B
| $12.3M | 1.38% |
246,489
+8,921
| +4% | +$444K |
|
|
33
Weyerhaeuser
WY
$17.9B
| $11.9M | 1.33% |
349,184
+220,910
| +172% | +$7.52M |
|
|
RDS.B
34
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $11.1M | 1.24% |
177,279
+4,179
| +2% | +$261K |
|
35
Chevron
CVX
$325B
| $10.9M | 1.22% |
92,863
+579
| +0.6% | +$68K |
|
|
36
Vodafone
VOD
$28.2B
| $10.8M | 1.22% |
380,604
-126,179
| -25% | -$3.59M |
|
|
37
Albemarle
ALB
$9.34B
| $10.5M | 1.18% |
76,870
+18,385
| +31% | +$2.51M |
|
38
Corning
GLW
$58.2B
| $10.5M | 1.17% |
349,252
-5,965
| -2% | -$178K |
|
39
Gilead Sciences
GILD
$139B
| $10.4M | 1.16% |
128,070
+26,167
| +26% | +$2.12M |
|
40
Synopsys
SNPS
$109B
| $9.95M | 1.12% |
123,493
-8,525
| -6% | -$687K |
|
41
Walt Disney
DIS
$210B
| $9.76M | 1.1% |
98,986
+12,175
| +14% | +$1.2M |
|
42
Novartis
NVS
$244B
| $9.72M | 1.09% |
113,247
+15,575
| +16% | +$1.34M |
|
43
Brunswick
BC
$4.12B
| $9.47M | 1.06% |
169,200
+28,090
| +20% | +$1.57M |
|
|
44
US Bancorp
USB
$74.7B
| $9.19M | 1.03% |
171,557
+99,761
| +139% | +$5.35M |
|
45
Unilever
UL
$156B
| $9.16M | 1.03% |
158,089
-549
| -0.3% | -$31.8K |
|
46
Amgen
AMGN
$153B
| $7.68M | 0.86% |
41,196
-7,821
| -16% | -$1.46M |
|
47
Trimble
TRMB
$18.6B
| $7.22M | 0.81% |
183,823
-3,645
| -2% | -$143K |
|
48
Berkshire Hathaway Class A
BRK.A
$1.08T
| $7.14M | 0.8% |
26
-1
| -4% | -$275K |
|
49
Mondelez International
MDLZ
$79.9B
| $6.11M | 0.69% |
150,348
-924
| -0.6% | -$37.6K |
|
50
Thermo Fisher Scientific
TMO
$182B
| $5.89M | 0.66% |
31,119
-740
| -2% | -$140K |
|